clinical trial · NCT05903924
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
Motion SicknessTradipitantPlacebo
brief summary
A multi-center, randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in participants affected by motion sickness during travel
started
Sep 9, 2023
primary completion
Apr 6, 2024
completion
Apr 24, 2024
last updated
Apr 4, 2025
official title
Motion Serifos: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol